Cargando…
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
AIM: Herein, we compare outcomes in patients treated with lung stereotactic body radiotherapy (SBRT) with and without tissue confirmation. METHODS: We reviewed 196 patients that underwent lung SBRT for presumed (100 patients) or proven non-small-cell lung cancer (96 patients) over a 10-year period a...
Autores principales: | Wegner, Rodney E, Ahmed, Nissar, Hasan, Shaakir, Schumacher, Lana Y, Van Deusen, Matthew, Colonias, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307539/ https://www.ncbi.nlm.nih.gov/pubmed/30643580 http://dx.doi.org/10.2217/lmt-2018-0006 |
Ejemplares similares
-
Image‐based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10‐year single institution experience
por: Hasan, Shaakir, et al.
Publicado: (2018) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019) -
Stereotactic body radiotherapy for central lung tumors: Finding the balance between safety and efficacy in the “no fly” zone
por: Ahmed, Nissar, et al.
Publicado: (2018) -
Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series
por: Wegner, Rodney E, et al.
Publicado: (2018) -
Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)